These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33964186)

  • 1. Association of preoperative infections, nasal Staphylococcus aureus colonization and gut microbiota with left ventricular assist device outcomes.
    Yuzefpolskaya M; Lumish HS; Javaid A; Cagliostro B; Mondellini GM; Bohn B; Sweat A; Onat D; Braghieri L; Takeda K; Naka Y; Sayer GT; Uriel N; Aaron JG; Montassier E; Demmer RT; Colombo PC
    Eur J Heart Fail; 2021 Aug; 23(8):1404-1415. PubMed ID: 33964186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota, endotoxemia, inflammation, and oxidative stress in patients with heart failure, left ventricular assist device, and transplant.
    Yuzefpolskaya M; Bohn B; Nasiri M; Zuver AM; Onat DD; Royzman EA; Nwokocha J; Mabasa M; Pinsino A; Brunjes D; Gaudig A; Clemons A; Trinh P; Stump S; Giddins MJ; Topkara VK; Garan AR; Takeda K; Takayama H; Naka Y; Farr MA; Nandakumar R; Uhlemann AC; Colombo PC; Demmer RT
    J Heart Lung Transplant; 2020 Sep; 39(9):880-890. PubMed ID: 32139154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Existing evidence supports clinical trials on interventions preventing ventricular assist device infection in patients colonized with Staphylococcus aureus. Letter regarding the article 'Association of preoperative infections, nasal Staphylococcus aureus colonization and gut microbiota with left ventricular assist device outcomes'.
    Nurjadi D; Ruhparwar A; Zanger P
    Eur J Heart Fail; 2021 Sep; 23(9):1566. PubMed ID: 34092016
    [No Abstract]   [Full Text] [Related]  

  • 4. Outcomes of left ventricular assist device implantation for advanced heart failure in critically ill patients (INTERMACS 1 and 2): A retrospective study.
    Zhigalov K; Van den Eynde J; Chrosch T; Goerdt L; Sá MPBO; Zubarevich A; Papathanasiou M; Wendt D; Luedike P; Pizanis N; Koch A; Schmack B; Rassaf T; Kamler M; Ruhparwar A; Weymann A
    Artif Organs; 2021 Jul; 45(7):706-716. PubMed ID: 33350481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative right ventricular failure after left ventricular assist device placement is predicted by preoperative echocardiographic structural, hemodynamic, and functional parameters.
    Raina A; Seetha Rammohan HR; Gertz ZM; Rame JE; Woo YJ; Kirkpatrick JN
    J Card Fail; 2013 Jan; 19(1):16-24. PubMed ID: 23273590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of infection among left ventricular assist device recipients on post-transplantation outcomes: A retrospective review.
    Lerman DT; Hamilton KW; Byrne D; Lee DF; Zeitler K; Claridge T; Gray J; Minamoto GY
    Transpl Infect Dis; 2018 Dec; 20(6):e12995. PubMed ID: 30199584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular assist device outcomes based on flow configuration and pre-operative left ventricular dimension: An Interagency Registry for Mechanically Assisted Circulatory Support Analysis.
    Shah P; Birk S; Maltais S; Stulak J; Elmi A; Pagani FD; Cowger JA
    J Heart Lung Transplant; 2017 Jun; 36(6):640-649. PubMed ID: 28087105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of narrowing perioperative antibiotic prophylaxis for left ventricular assist device implantation.
    Allen L; Bartash R; Minamoto GY; Cowman K; Patel S; Vukelic S; Nnani DU; Fauvel D; Guo Y
    Transpl Infect Dis; 2022 Oct; 24(5):e13900. PubMed ID: 35785460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of Trimethylamine N-Oxide Remain Elevated Long Term After Left Ventricular Assist Device and Heart Transplantation and Are Independent From Measures of Inflammation and Gut Dysbiosis.
    Yuzefpolskaya M; Bohn B; Javaid A; Mondellini GM; Braghieri L; Pinsino A; Onat D; Cagliostro B; Kim A; Takeda K; Naka Y; Farr M; Sayer GT; Uriel N; Nandakumar R; Mohan S; Colombo PC; Demmer RT
    Circ Heart Fail; 2021 Jun; 14(6):e007909. PubMed ID: 34129361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Independent risk factors for ICU mortality after left ventricular assist device implantation.
    Piffard M; Nubret-Le Coniat K; Simon O; Leuillet S; Rémy A; Barandon L; Ouattara A
    Artif Organs; 2020 Feb; 44(2):153-161. PubMed ID: 31318978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal colonization with Staphylococcus aureus is a risk factor for ventricular assist device infection in the first year after implantation: A prospective, single-centre, cohort study.
    Nurjadi D; Last K; Klein S; Boutin S; Schmack B; Mueller F; Heeg K; Ruhparwar A; Heininger A; Zanger P
    J Infect; 2020 May; 80(5):511-518. PubMed ID: 32112885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Causes and predictors of early mortality in patients treated with left ventricular assist device implantation in the European Registry of Mechanical Circulatory Support (EUROMACS).
    Akin S; Soliman O; de By TMMH; Muslem R; Tijssen JGP; Schoenrath F; Meyns B; Gummert JF; Mohacsi P; Caliskan K;
    Intensive Care Med; 2020 Jul; 46(7):1349-1360. PubMed ID: 32016536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of preoperative serum albumin levels to survival in patients undergoing left ventricular assist device implantation.
    Kato TS; Kitada S; Yang J; Wu C; Takayama H; Naka Y; Farr M; Mancini DM; Schulze PC
    Am J Cardiol; 2013 Nov; 112(9):1484-8. PubMed ID: 23891248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypotension on cardiopulmonary stress test predicts 90 day mortality after LVAD implantation in INTERMACS 3-6 patients.
    Maharaj V; Agdamag AC; Duval S; Edmiston J; Charpentier V; Fraser M; Hall A; Schultz J; John R; Shaffer A; Martin CM; Thenappan T; Francis GS; Cogswell R; Alexy T
    ESC Heart Fail; 2022 Oct; 9(5):3496-3504. PubMed ID: 35883259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of age on outcomes following continuous-flow left ventricular assist device implantation.
    Lushaj EB; Badami A; Osaki S; Murray M; Leverson G; Lozonschi L; Akhter S; Kohmoto T
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):743-8. PubMed ID: 25770085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictor of early mortality for severe heart failure patients with left ventricular assist device implantation: significance of INTERMACS level and renal function.
    Yoshioka D; Sakaguchi T; Saito S; Miyagawa S; Nishi H; Yoshikawa Y; Fukushima S; Saito T; Daimon T; Ueno T; Kuratani T; Sawa Y
    Circ J; 2012; 76(7):1631-8. PubMed ID: 22484979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of global and disease-specific health status with outcomes following continuous-flow left ventricular assist device implantation.
    Flint KM; Spertus JA; Tang F; Jones P; Fendler TJ; Allen LA
    BMC Cardiovasc Disord; 2017 Mar; 17(1):78. PubMed ID: 28288574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracorporeal life support prior to left ventricular assist device implantation leads to improvement of the patients INTERMACS levels and outcome.
    Schibilsky D; Haller C; Lange B; Schibilsky B; Haeberle H; Seizer P; Gawaz M; Rosenberger P; Walker T; Schlensak C
    PLoS One; 2017; 12(3):e0174262. PubMed ID: 28358849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Right heart failure before LVAD implantation predicts right heart failure after LVAD implantation - is it that easy?
    Wagner T; Bernhardt AM; Magnussen C; Reichenspurner H; Blankenberg S; Grahn H
    J Cardiothorac Surg; 2020 May; 15(1):113. PubMed ID: 32450890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.